<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="046f7cc0-5b8b-4647-8274-3a9f3554b5b9"/>
   <code code="34391-3" displayName="HUMAN PRESCRIPTION DRUG LABEL" codeSystem="2.16.840.1.113883.6.1"/>
   <title>0.9% Sodium Chloride Injection USP</title>
   <effectiveTime value="20240508"/>
   <setId root="47a0313f-36df-4fa6-a828-c9e1946ba9b0"/>
   <versionNumber value="14"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="002397347" root="1.3.6.1.4.1.519.1"/>
            <name>B. Braun Medical Inc.</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="037425308" root="1.3.6.1.4.1.519.1"/>
                        <name>B. Braun US Pharmaceutical Manufacturing LLC</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C84732" displayName="label" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0264-7800" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0264-7800" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" displayName="pack" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0264-7800" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="5ba95ccd-31a9-4da7-83bf-da0d2cf0ade7"/>
               <code code="48780-1" displayName="SPL listing data elements section" codeSystem="2.16.840.1.113883.6.1"/>
               <effectiveTime value="20240508"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0264-7800" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Sodium Chloride</name>
                        <formCode code="C42945" displayName="INJECTION, SOLUTION" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Sodium Chloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="0.9"/>
                              <denominator unit="mL" value="100"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="Q32ZN48698" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CHLORIDE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="1000"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43186" displayName="CONTAINER" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="12"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0264-7800-09" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43184" displayName="CASE" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20131231"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" displayName="Type 0: Not a Combination Product" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA019635" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" displayName="NDA" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20131231"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" displayName="INTRAVENOUS" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="LINK_fb5a6a7e-242c-4049-a40b-61449bbfc419">
               <id root="5b1c9d2f-9119-4f90-add9-e8f9382bb946"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION</title>
               <text>
                  <paragraph>Each 100 mL of <content styleCode="bold">0.9% Sodium Chloride Injection USP</content> contains:</paragraph>
                  <paragraph>Sodium Chloride USP 0.9 g; Water for Injection USP qs</paragraph>
                  <paragraph>pH: 5.6 (4.5-7.0)</paragraph>
                  <paragraph>Calculated Osmolarity: 308 mOsmol/liter</paragraph>
                  <paragraph>pH adjusted with Hydrochloric Acid NF</paragraph>
                  <paragraph>Concentration of Electrolytes (mEq/liter):  Sodium 154;      Chloride 154</paragraph>
                  <paragraph>Sodium Chloride Injection USP is sterile, nonpyrogenic, isotonic and contains no bacteriostatic or antimicrobial agents.</paragraph>
                  <paragraph>The formula of the active ingredient is:</paragraph>
                  <table>
                     <col/>
                     <col/>
                     <col/>
                     <tbody>
                        <tr>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule">
                              <content styleCode="bold">Ingredient</content> </td>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> <content styleCode="bold">Molecular Formula</content>
                           </td>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> <content styleCode="bold">Molecular Weight</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> Sodium Chloride USP</td>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> NaCl</td>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> 58.44</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>Not made with natural rubber latex, PVC, or DEHP.</paragraph>
                  <paragraph>The plastic container is made from a homogenous blend of polypropylene and thermoplastic modifier specifically developed for parenteral drugs. The container is nontoxic and biologically inert. The container is a closed system and is not dependent upon entry of external air during administration. </paragraph>
                  <paragraph>Addition of medication should be accomplished using complete aseptic technique.</paragraph>
                  <paragraph>The closure system has two ports; one for the administration set and the other is a medication addition site. Each port has a tamper evident cover. Refer to the Directions for Use of the container.</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_137d99ae-d713-4464-ba18-7ffbcfd3b5b0">
               <id root="b77bf182-b6e3-4734-be4b-ca8039f28b7e"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>Sodium Chloride Injection USP provides electrolytes and is a source of water for hydration. It is capable of inducing diuresis depending on the clinical condition of the patient.</paragraph>
                  <paragraph>Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.</paragraph>
                  <paragraph>Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration.</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_4982f96f-9dda-4a1a-b67d-bdb97ab4213e">
               <id root="ad2d1685-7d33-45ce-8d9a-20c6493258b7"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration.</paragraph>
                  <paragraph>0.9% Sodium Chloride Injection USP is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion.</paragraph>
                  <paragraph>0.9% Sodium Chloride Injection USP is also indicated for use as a priming solution in hemodialysis procedures and may be used to initiate and terminate blood transfusions without hemolyzing red blood cells.</paragraph>
                  <paragraph>Sodium Chloride Injection USP is also indicated as a pharmaceutic aid and diluent for the infusion of compatible drug additives. Refer to prescribing information accompanying additive drugs.</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_3e23aeb3-6b17-40f2-8742-ac9fef373de2">
               <id root="1465508a-1cfa-45d5-8595-29d473e16779"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS</title>
               <text>
                  <paragraph>This solution is contraindicated where the administration of sodium or chloride could be clinically detrimental.</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_3ef0ec64-d535-42c5-99c1-df1ba44986b4">
               <id root="f0362c9a-67a1-499c-855d-16fa8afb72c7"/>
               <code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION"/>
               <title>WARNINGS</title>
               <text>
                  <paragraph>The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentration. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentration.</paragraph>
                  <paragraph>Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there is sodium retention with edema. In patients with diminished renal function, administration of solutions containing sodium ions may result in sodium retention.</paragraph>
                  <paragraph>Infusion of isotonic (0.9%) sodium chloride during or immediately after surgery may result in excessive sodium retention. Use the patient’s circulatory system status as a guide.</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_9b6088ca-9be5-414c-b564-6a25bb1ed1d4">
               <id root="f4d1b745-de57-4411-985a-dbc2c547a830"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <effectiveTime value="20240508"/>
               <component>
                  <section ID="LINK_f2c55481-c2f5-4af7-9428-f40c66d1ca74">
                     <id root="2bdc88eb-25dc-42fc-80a1-4de778ab3021"/>
                     <code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION"/>
                     <title>General</title>
                     <text>
                        <paragraph>Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Significant deviations from normal concentrations may require tailoring of the electrolyte pattern, in these or alternative solutions.</paragraph>
                        <paragraph>This solution should be used with care in patients with hypervolemia, renal insufficiency, urinary tract obstruction, or impending or frank cardiac decompensation.</paragraph>
                        <paragraph>Extraordinary electrolyte losses such as may occur during protracted nasogastric suction, vomiting, diarrhea or gastrointestinal fistula drainage may necessitate additional electrolyte supplementation. Additional essential electrolytes, minerals and vitamins should be supplied as needed.</paragraph>
                        <paragraph>Sodium-containing solutions should be administered with caution to patients receiving corticosteroids or corticotropin, or to other salt-retaining patients. Care should be exercised in administering solutions containing sodium to patients with renal or cardiovascular insufficiency, with or without congestive heart failure, particularly if they are postoperative or elderly.</paragraph>
                        <paragraph>Infusion of more than one liter of isotonic (0.9%) sodium chloride per day may supply more sodium and chloride than normally found in serum, and can exceed normal tolerance, resulting in hypernatremia; this may also cause a loss of bicarbonate ions, resulting in an acidifying effect.</paragraph>
                        <paragraph>To minimize the risk of possible incompatibilities arising from mixing this solution with other additives that may be prescribed, the final infusate should be inspected for cloudiness or precipitation immediately after mixing, prior to administration and periodically during administration.</paragraph>
                        <paragraph>Do not use plastic container in series connection.</paragraph>
                        <paragraph>If administration is controlled by a pumping device, care must be taken to discontinue pumping action before the container runs dry or air embolism may result. </paragraph>
                        <paragraph>This solution is intended for intravenous administration using sterile equipment. It is recommended that intravenous administration apparatus be replaced at least once every 24 hours.</paragraph>
                        <paragraph>Use only if solution is clear and container and seals are intact.</paragraph>
                     </text>
                     <effectiveTime value="20240508"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_38d53e0d-7c5b-4056-b9dc-4c68200eaaed">
                     <id root="6e46f27f-6b72-4782-bfb1-2568e4755097"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph>Studies with Sodium Chloride Injection USP have not been performed to evaluate carcinogenic potential, mutagenic potential or effects on fertility.</paragraph>
                     </text>
                     <effectiveTime value="20240508"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_d6bf89c1-03d7-4673-9a10-290207ac8734">
                     <id root="cda37cdd-8f51-48f1-866c-fb34416aa767"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>Pregnancy</title>
                     <effectiveTime value="20240508"/>
                     <component>
                        <section ID="LINK_b7fb3f7a-a201-4e88-8a91-395be15323a0">
                           <id root="a98c40c1-9e1a-4684-9457-88c28b2313ec"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <title>- Teratogenic Effects</title>
                           <text>
                              <paragraph>Animal reproduction studies have not been conducted with Sodium Chloride Injection USP. It is also not known whether Sodium Chloride Injection USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Chloride Injection USP should be given to a pregnant woman only if clearly needed.</paragraph>
                           </text>
                           <effectiveTime value="20240508"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="LINK_8a8586ac-b964-493a-a476-873aeeb35a37">
                     <id root="a62c8a14-58cc-46f0-a445-45d2ef4765e8"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title>Nursing Mothers</title>
                     <text>
                        <paragraph>It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Sodium Chloride Injection USP is administered to a nursing woman.</paragraph>
                     </text>
                     <effectiveTime value="20240508"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_18aeec53-a6ea-4e7b-89b7-6380972dce01">
                     <id root="b80b96d8-1d4d-4675-b135-e822b1d54e33"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>Pediatric Use</title>
                     <text>
                        <paragraph>Safety and effectiveness of sodium chloride injections in pediatric patients have not been established by adequate and well controlled trials, however, the use of electrolyte solutions in the pediatric population is referenced in the medical literature. The warnings, precautions and adverse reactions identified in the label copy should be observed in the pediatric population.</paragraph>
                     </text>
                     <effectiveTime value="20240508"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_66ce9542-f256-4e93-b045-8653f1725aa6">
                     <id root="3608126e-b679-4013-8f12-2e41791ae88e"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>Geriatric Use</title>
                     <text>
                        <paragraph>An evaluation of current literature revealed no clinical experience identifying differences in response between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</paragraph>
                        <paragraph>This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</paragraph>
                     </text>
                     <effectiveTime value="20240508"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_0bf2112e-4fe8-4425-8d5a-01b2fca1f8a5">
               <id root="1c353696-af82-4abc-bad0-749ab26a8b4e"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.</paragraph>
                  <paragraph>The physician should also be alert to the possibility of adverse reactions to drug additives. Prescribing information for drug additives to be administered in this manner should be consulted.</paragraph>
                  <paragraph>Symptoms may result from an excess or deficit of one or more of the ions present in the solution; therefore, frequent monitoring of electrolyte levels is essential.</paragraph>
                  <paragraph>Hypernatremia may be associated with edema and exacerbation of congestive heart failure due to the retention of water, resulting in an expanded extracellular fluid volume.</paragraph>
                  <paragraph>If infused in large amounts, chloride ions may cause a loss of bicarbonate ions, resulting in an acidifying effect.</paragraph>
                  <paragraph>If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_01adae12-3df7-4cc8-8b7e-c39845632832">
               <id root="9b101053-2106-47aa-9e97-694656271aad"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>OVERDOSAGE</title>
               <text>
                  <paragraph>In the event of a fluid or solute overload during parenteral therapy, reevaluate the patient’s condition and institute appropriate corrective treatment.</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_96c1dfaf-ee7b-4cda-8a16-33ce5a467413">
               <id root="fbc63f0c-9624-4174-abe0-7801314d1326"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>This solution is for intravenous use only.</paragraph>
                  <paragraph>Dosage is to be directed by a physician and is dependent upon age, weight, clinical condition of the patient and laboratory determinations. Frequent laboratory determinations and clinical evaluation are essential to monitor changes in blood glucose and electrolyte concentrations, and fluid and electrolyte balance during prolonged parenteral therapy.</paragraph>
                  <paragraph>In the average adult, daily requirements of sodium and chloride are met by the infusion of one liter of 0.9% sodium chloride (154 mEq each of sodium and chloride).</paragraph>
                  <paragraph>There is no specific pediatric dose. The dose is dependent on weight, clinical condition and laboratory results. Follow recommendations of appropriate pediatric reference text. (See <content styleCode="bold">
                        <linkHtml href="#www.splportal.comLINK_18aeec53-a6ea-4e7b-89b7-6380972dce01">PRECAUTIONS,</linkHtml>
                        <content styleCode="italics">
                           <linkHtml href="#www.splportal.comLINK_18aeec53-a6ea-4e7b-89b7-6380972dce01"> Pediatric Use</linkHtml>
                        </content>
                        <content styleCode="italics">.</content>
                     </content>)</paragraph>
                  <paragraph>Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient.</paragraph>
                  <paragraph>0.9% Sodium Chloride Injection USP may also be administered intravascularly as a priming fluid in hemodialysis procedures.</paragraph>
                  <paragraph>When Sodium Chloride Injection USP is used as a diluent for infusion of compatible drug additives, refer to dosage and administration information accompanying additive drugs.</paragraph>
                  <paragraph>Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</paragraph>
                  <paragraph>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_3e914197-ce5d-4ad3-88c1-1ca52ca9d16d">
               <id root="ec2054ea-e22e-41f3-97bc-15d4e998810f"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>Sodium Chloride Injection USP is supplied sterile and nonpyrogenic in Plastic Containers packaged 12 per case.</paragraph>
                  <table>
                     <col/>
                     <col/>
                     <col/>
                     <tbody>
                        <tr>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> <content styleCode="bold">NDC</content>
                           </td>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> <content styleCode="bold">REF</content>
                           </td>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> <content styleCode="bold">Size</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> 0264-7800-09</td>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> E8000</td>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> 1000 mL</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.]</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_c3bd33b6-78e7-4a0a-9e44-57607c07c9c0">
               <id root="90307391-a89b-4869-a5fb-b3b81377cafc"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Directions for Use of Plastic Container</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Caution:</content> Do not use plastic container in series connection.</paragraph>
                  <paragraph>
                     <content styleCode="bold">To Open</content>
                  </paragraph>
                  <paragraph>Check for minute leaks by squeezing solution container firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below before preparing for administration.</paragraph>
                  <paragraph>
                     <content styleCode="bold">NOTE:</content>    Before use, perform the following checks:</paragraph>
                  <paragraph>Inspect each container. Read the label. Ensure solution is the one ordered and is within the expiration date.</paragraph>
                  <paragraph>Invert container and carefully inspect the solution in good light for cloudiness, haze, or particulate matter. Any container which is suspect should not be used.</paragraph>
                  <paragraph>Use only if solution is clear and container and seals are intact.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Preparation for Administration</content>
                  </paragraph>
                  <list listType="ordered" styleCode="Arabic">
                     <item>Remove plastic protector from sterile set port at bottom of container.</item>
                     <item>Attach administration set. Refer to complete directions accompanying set.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">To Add Medication</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Warning:</content> Some additives may be incompatible.</paragraph>
                  <paragraph>
                     <content styleCode="bold">To Add Medication Before Solution Administration</content>
                  </paragraph>
                  <list listType="ordered" styleCode="Arabic">
                     <item>Prepare medication site by removing the additive port closure. Swab the exposed medication site before puncturing.</item>
                     <item>Using syringe with 18-22 Ga. needle, puncture medication port and inner diaphragm and inject.</item>
                     <item>Squeeze and tap ports while ports are upright and mix solution and medication thoroughly.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">To Add Medication During Solution Administration</content>
                  </paragraph>
                  <list listType="ordered" styleCode="Arabic">
                     <item>Close clamp on the set.</item>
                     <item>Prepare medication site by removing the additive port closure. Swab the exposed medication site before puncturing.</item>
                     <item>Using syringe with 18-22 Ga. needle of appropriate length (at least 5/8 inch), puncture resealable medication port and inner diaphragm and inject.</item>
                     <item>Remove container from IV pole and/or turn to an upright position.</item>
                     <item>Evacuate both ports by tapping and squeezing them while container is in the upright position.</item>
                     <item>Mix solution and medication thoroughly.</item>
                     <item>Return container to in use position and continue administration.</item>
                  </list>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_d5658c92-36bd-4e16-b6f5-0543ec7d7df6">
               <id root="34d1c238-a62b-42e5-ab95-f8d1aa6f91b9"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <title/>
               <text>
                  <paragraph>Revised: December 2022</paragraph>
                  <paragraph>LD-436-4 Y36-003-070</paragraph>
                  <paragraph>Package Insert</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>
                     <content styleCode="bold">B. Braun Medical Inc.<br/>
                     </content>Bethlehem, PA 18018-3524 USA<br/>
1-800-227-2862</paragraph>
               </text>
               <effectiveTime value="20240508"/>
            </section>
         </component>
         <component>
            <section ID="LINK_447d3c2e-2c98-4e94-9ed3-b260b96fc7d5">
               <id root="b732123d-d99a-407c-bfae-60211be2233e"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">0.9% Sodium Chloride Injection USP</content>
                  </paragraph>
                  <paragraph>REF  E8000<br/>
NDC  0264-7800-09</paragraph>
                  <paragraph>
                     <content styleCode="bold">1000 mL</content>
                  </paragraph>
                  <paragraph>Each 100 mL contains:<br/>
Sodium Chloride USP 0.9 g<br/>
Water for Injection USP qs</paragraph>
                  <paragraph>pH adjusted with HCl NF<br/>
pH: 5.6 (4.5-7.0)</paragraph>
                  <paragraph>Calc. Osmolarity: 308 mOsmol/liter<br/>
Electrolytes (mEq/liter): Na<sup>+</sup> 154    Cl<sup>–</sup> 154<br/>
Sterile. Single dose container.<br/>
For intravenous use only.</paragraph>
                  <paragraph>
                     <content styleCode="bold">WARNINGS:</content> Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</paragraph>
                  <paragraph>Recommended Storage:<br/>
Room temperature (25°C). Avoid excessive heat. Protect from freezing. See Package Insert.</paragraph>
                  <paragraph>Use only if solution is clear and container and seals are intact.</paragraph>
                  <paragraph>Not made with natural rubber latex, DEHP, or PVC.</paragraph>
                  <paragraph>Rx only</paragraph>
                  <renderMultiMedia referencedObject="MM1"/>
                  <paragraph>
                     <content styleCode="bold">B. Braun Medical Inc.<br/>
                     </content>Irvine, CA 92614-5895 USA<br/>
1-800-227-2862<br/>
                     <linkHtml href="http://www.bbraun.com">www.bbraun.com</linkHtml>
                     <br/>
Made in USA</paragraph>
                  <paragraph>Y38-000-059     LD-362-6</paragraph>
                  <paragraph>ADD        SET</paragraph>
                  <renderMultiMedia referencedObject="MM2">
                     <caption>E8000 Container Label</caption>
                  </renderMultiMedia>
               </text>
               <effectiveTime value="20240508"/>
               <component>
                  <observationMedia ID="MM1">
                     <text>Recycle - 7</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="sodium-chloride-injection-usp-in-exceed-1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM2">
                     <text>E8000 Container Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="sodium-chloride-injection-usp-in-exceed-2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>